On the current debate on lowering LDL cholesterine with ezetimibe

被引：1
|
作者：
Erdmann, E. [1 ]
机构：
[1] Herzzentrum Univ Koln, Klin Kardiol Angiol Pneumol & Internist Intensivm, D-50937 Cologne, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2010年 / 135卷 / 36期
关键词：
LDL cholesterine; Ezetimibe; Simvastatin; Surrogate parameter;
D O I：
10.1055/s-0030-1263304
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1742 / 1742
页数：1
相关论文
共 50 条
  • [1] On the current debate on lowering LDL cholesterol with ezetimibe Reply
    Erdmann, Erland
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 (44) : 2202 - 2202
  • [2] Lowering LDL cholesterol, but not raising LDL receptor activity, by ezetimibe
    Hayashi, Hiroshi
    Kawamura, Mitsunobu
    JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (06) : 632 - 636
  • [3] Lowering LDL Cholesterol, but not Raising LDL Receptor Activity, by Ezetimibe
    Hayashi, Hiroshi
    Kawamura, Mitsunobu
    CIRCULATION, 2012, 126 (21)
  • [4] Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?
    Brown, B. Greg
    Taylor, Allen J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14): : 1504 - 1507
  • [5] Variability of the LDL-C lowering response to ezetimibe and ezetimibe plus statin therapy in hypercholesterolemic patients
    Descamps, Olivier
    Tomassini, Joanne E.
    Lin, Jianxin
    Polis, Adam B.
    Shah, Arvind
    Brudi, Philippe
    Hanson, Mary E.
    Tershakovec, Andrew M.
    ATHEROSCLEROSIS, 2015, 240 (02) : 482 - 489
  • [6] Adding ezetimibe to statin treatment: is LDL-C lowering the only benefit?
    Kostapanos, Michael S.
    Mikhailidis, Dimitri P.
    Elisaf, Moses S.
    FUTURE CARDIOLOGY, 2012, 8 (06) : 813 - 817
  • [7] Cholesterol lowering and ezetimibe
    Drazen, Jeffrey M.
    Jarcho, John A.
    Morrissey, Stephen
    Curfman, Gregory D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14): : 1507 - 1508
  • [8] Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events
    Ahmed, M. H.
    Byrne, C. D.
    DIABETES OBESITY & METABOLISM, 2010, 12 (11): : 958 - 966
  • [9] The lowering of small dense LDL in patients with the metabolic syndrome by simvastatin/ezetimibe versus fluvastatin/fenofibrate
    Westphal, S.
    Abletshauser, C.
    Borucki, K.
    Klima, H.
    Luley, C.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A151 - A151
  • [10] LDL lowering effect of Ezetimibe 5 and 10 mg in clinical practice: A potential billion dollar savings
    Baruch, Lawrence
    Lieberman, Sharon
    Gupta, Bhanu
    Eng, Calvin
    Peters, James J.
    CIRCULATION, 2007, 116 (16) : 847 - 847
12345